In these studies, DSF was considered only as an acetaldehyde dehydrogenase (ALDH) inhibitor based on its classic function of treating alcohol addiction, but given its new status, the drug's function as an inhibitor of pyroptosis in glioma needs to be re-examined to guide the screening of suitable patients. The gene discussed is LDHA; the disease is glioma.